Safety and Efficacy of Indacaterol Once Daily Versus Salmeterol Twice Daily in Chronic Obstructive Pulmonary Disease (COPD)
Clinical trial NCT00821093 · COMPLETED
Trial details
- NCT number
- NCT00821093
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2009-01-01
- Primary completion
- 2009-10-01
- Enrollment
- 1123
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.